Novagold Resources Inc (NG) 3.05 $NG Novagold Resources

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Novagold Resources Inc (NG) 3.05 $NG

Novagold Resources Down 7.3%, Shares Slide into the Red (NG)
Comtex SmarTrend(R) - Mon Mar 16, 12:53PM CDT
Novagold Resources (AMEX:NG) is one of today's worst performing low-priced stocks, down 7.3% to $2.90 on 1.0x average daily volume. Novagold Resources has traded 2.1 million shares thus far today, vs. average volume of 2.0 million shares per day. The stock has underperformed the Dow (-7.3% to the Dow's 1.0%) and underperformed the S&P 500 (-7.3% to the S&P's 1.0%) during today's trading.
NG: 3.05 (+0.03)

The Simple Test Tocqueville's John Hathaway And Doug Groh Use To Determine If Gold Is At A Bottom
The Gold Report - at Seeking Alpha - Thu Mar 12, 12:55AM CDT
Gold investors have been through a nuclear winter, but the future looks bright as mining companies bask in the glow of lower costs, better exchange rates and a flurry of mergers and acquisitions. In this interview with The Gold Report, Tocqueville...
BTG: 1.63 (+0.11), NEM: 22.95 (+0.13), NG: 3.05 (+0.03), RIOM: 2.68 (+0.10), SLW: 20.19 (+0.77), RGLD: 67.51 (+1.25), SLV: 16.00 (+0.56), TAHO: 11.83 (+0.34), SA: 6.29 (-0.07)

SAVE THE DATE: NOVAGOLD First Quarter 2015 Results Release, Conference Call and Webcast
Marketwired - Wed Mar 11, 3:40PM CDT
NOVAGOLD RESOURCES INC. (TSX: NG)(NYSE MKT: NG) will release its first quarter financial results after market close March 31st, 2015. The conference call and webcast, to discuss these results, will take place April 1st, 2015 at 8:00 am PT (11:00 am ET). The webcast and conference call-in details are provided below.
NG.TO: 4.03 (+0.17), NG: 3.05 (+0.03)

After Hours Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 4:42PM CST

VEEV: 27.28 (-0.65), NG: 3.05 (+0.03), CRIS: 2.73 (-0.13), EVTC: 22.61 (+0.01), GTN: 14.42 (-0.04), SM: 47.09 (+1.88), MNKD: 5.26 (-0.28), RIGL: 3.45 (-0.06), EXK: 2.06 (unch), WBAI: 11.06 (+1.08)

Precious metals and miners slammed by interest rate fears
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 1:42PM CST

GLDI: 11.72 (+0.09), BTG: 1.63 (+0.11), OUNZ: 11.79 (+0.12), AUQ: 2.99 (+0.01), HL: 3.19 (+0.06), SIVR: 16.44 (+0.56), DSLV: 53.12 (-7.07), SGOL: 115.86 (+1.34), KGC: 2.42 (+0.06), SLW: 20.19 (+0.77), SLV: 16.00 (+0.56), GDX: 19.33 (+0.62), UGL: 38.08 (+0.77), BARS: 47.25 (-1.58), GOLD: 72.18 (+1.60), AU: 9.84 (+0.44), DZZ: 7.35 (-0.15), SIL: 8.90 (+0.26), IAG: 2.03 (+0.04), DGL: 39.03 (+0.43), NUGT: 11.26 (+1.03), GLTR: 61.41 (+1.07), DGP: 23.18 (+0.53), NG: 3.05 (+0.03), UBG: 30.56 (+0.27), DGZ: 15.52 (-0.17), FNV: 51.27 (+2.05), PAAS: 9.50 (+0.27), IAU: 11.44 (+0.13), RGLD: 67.51 (+1.25), WITE: 33.41 (+0.73), AGOL: 113.86 (unch), AUY: 3.91 (+0.20), UGLD: 10.99 (+0.33), GFI: 4.36 (+0.15), GYEN: 13.06 (+0.01), JJP: 56.85 (+1.25), GEUR: 13.79 (-0.02), AGQ: 42.25 (+2.95), EGO: 5.09 (+0.21), DUST: 16.25 (-1.88), BLNG: 30.80 (-1.60), AGI: 6.25 (+0.21), ZSL: 100.25 (-7.75), TBAR: 23.82 (-0.05), ABX: 11.10 (+0.21), NEM: 22.95 (+0.13), USV: 22.54 (+1.01), DGLD: 74.82 (-2.68), DBS: 26.89 (+0.97), RGRP: 16.71 (+0.25), USLV: 21.12 (+2.11), SLVO: 11.45 (+0.33), DBP: 36.96 (+0.56), GLD: 113.57 (+1.28), BAR: 26.60 (+0.79), SBGL: 9.05 (+0.17), GG: 19.17 (+0.56), GLL: 98.55 (-2.23)

Seeking Baupost: The Hidden Holdings - Part III
Matthew Finston - at Seeking Alpha - Sat Feb 28, 5:35AM CST

OCN: 8.52 (+0.17), PRTK: 30.83 (+0.46), KOS: 8.24 (-0.11), KIN: 7.20 (+0.11), VSAT: 61.04 (unch), BXE: 2.38 (+0.03), EBAY: 57.93 (+0.05), SEMI: 27.14 (+1.76), TBPH: 19.38 (-0.06), THRX: 17.03 (-0.94), VRTV: 47.86 (-0.55), IMOS: 23.42 (-0.17), GLNG: 34.05 (-0.55), ELOS: 12.05 (-0.07), MU: 28.68 (+0.63), AR: 36.03 (+0.40), NCQ: 0.65 (-0.02), PBF: 32.09 (+0.37), LNG: 79.71 (+0.83), ATRA: 38.78 (+2.89), KERX: 14.31 (+0.68), NG: 3.05 (+0.03), AOI: 0.99 (+0.02), FWP: 22.89 (-1.01), ALDW: 19.62 (+0.39)

Donlin Gold And Galore Creek Are Long-Term Catalysts For NovaGold Resources
Anup Singh - at Seeking Alpha - Wed Feb 25, 9:15AM CST

NG: 3.05 (+0.03)

Seeking Baupost: The Himalayan Yeti Frightens
Matthew Finston - at Seeking Alpha - Tue Feb 24, 7:49AM CST

ELOS: 12.05 (-0.07), MU: 28.68 (+0.63), AR: 36.03 (+0.40), PBF: 32.09 (+0.37), OCN: 8.52 (+0.17), NCQ: 0.65 (-0.02), LNG: 79.71 (+0.83), ATRA: 38.78 (+2.89), PRTK: 30.83 (+0.46), KOS: 8.24 (-0.11), KIN: 7.20 (+0.11), VSAT: 61.04 (unch), KERX: 14.31 (+0.68), NG: 3.05 (+0.03), BXE: 2.38 (+0.03), AOI: 0.99 (+0.02), EBAY: 57.93 (+0.05), ALDW: 19.62 (+0.39), FWP: 22.89 (-1.01), SEMI: 27.14 (+1.76), VRTV: 47.86 (-0.55), THRX: 17.03 (-0.94), TBPH: 19.38 (-0.06), IMOS: 23.42 (-0.17)

Tracking John Paulson's Paulson & Company Portfolio - Q4 2014 Update
John Vincent - at Seeking Alpha - Mon Feb 23, 3:36AM CST

TLM: 7.61 (-0.04), HHC: 153.71 (+0.46), AET: 108.63 (+0.32), STAY: 19.94 (+0.37), DLTR: 83.81 (+0.41), AEM: 29.72 (+1.16), NPSP: 45.97 (+0.01), DG: 75.78 (+0.87), ABBV: 60.40 (-0.79), TMUS: 33.14 (-0.06), DXM: 5.04 (-0.08), CODE: 38.59 (+0.47), MNK: 132.47 (+1.26), GOLD: 72.18 (+1.60), NCQ: 0.65 (-0.02), COV: 106.71 (-1.36), AU: 9.84 (+0.44), SLXP: 172.80 (+0.26), IAG: 2.03 (+0.04), MYL: 63.06 (-0.88), FDO: 79.90 (+0.20), MGM: 22.62 (-0.23), HIG: 43.10 (+0.53), NG: 3.05 (+0.03), EQIX: 238.95 (+3.05), OAS: 13.80 (-0.16), PETM: 82.98 (+0.03), ACT: 317.06 (+2.65), MDT: 78.02 (+0.36), BPOP: 34.32 (+0.13), ENZY: 7.01 (+0.07), GFI: 4.36 (+0.15), CZR: 9.44 (unch), CVC: 18.68 (+0.59), CIE: 9.07 (-0.03), AGN: 240.22 (+2.88), CACQ: 6.99 (+0.09), T: 33.23 (+0.03), ECA: 11.10 (+0.28), S: 4.95 (-0.04), FCH: 11.91 (+0.51), SHPG: 253.64 (+3.07), DTV: 86.25 (+0.20), KMDA: 4.25 (-0.18), ANV: 0.86 (unch), BAC: 15.84 (+0.23), GRFS: 33.29 (+0.30), HCA: 76.03 (+0.61), POST: 48.54 (+1.40), RDN: 17.03 (+0.22), BEE: 12.95 (+0.34), GLD: 113.57 (+1.28), RLGY: 44.66 (+0.74), HMHC: 23.27 (+0.11), MTG: 9.88 (+0.22), CMCSA: 59.45 (+0.71), SBGL: 9.05 (+0.17), BABA: 85.20 (-0.54)

Seeking Baupost: The Pangs Of Value Investing - Part 1
Matthew Finston - at Seeking Alpha - Mon Feb 16, 9:28AM CST

ELOS: 12.05 (-0.07), MU: 28.68 (+0.63), AR: 36.03 (+0.40), PBF: 32.09 (+0.37), OCN: 8.52 (+0.17), NCQ: 0.65 (-0.02), LNG: 79.71 (+0.83), KOS: 8.24 (-0.11), KIN: 7.20 (+0.11), VSAT: 61.04 (unch), KERX: 14.31 (+0.68), NG: 3.05 (+0.03), BXE: 2.38 (+0.03), AOI: 0.99 (+0.02), EBAY: 57.93 (+0.05), ALDW: 19.62 (+0.39), BYD: 14.24 (-0.12), AVEO: 1.35 (-0.16), SEMI: 27.14 (+1.76), VRTV: 47.86 (-0.55), THRX: 17.03 (-0.94), TBPH: 19.38 (-0.06), IMOS: 23.42 (-0.17)

Tracking Seth Klarman's Baupost Group Holdings - Q4 2014 Update
John Vincent - at Seeking Alpha - Sun Feb 15, 1:07AM CST

OCN: 8.52 (+0.17), PRTK: 30.83 (+0.46), KOS: 8.24 (-0.11), KIN: 7.20 (+0.11), VSAT: 61.04 (unch), BXE: 2.38 (+0.03), EBAY: 57.93 (+0.05), SEMI: 27.14 (+1.76), VRTV: 47.86 (-0.55), THRX: 17.03 (-0.94), TBPH: 19.38 (-0.06), IMOS: 23.42 (-0.17), ELOS: 12.05 (-0.07), MU: 28.68 (+0.63), AR: 36.03 (+0.40), NCQ: 0.65 (-0.02), PBF: 32.09 (+0.37), LNG: 79.71 (+0.83), ATRA: 38.78 (+2.89), KERX: 14.31 (+0.68), NG: 3.05 (+0.03), AOI: 0.99 (+0.02), QRVO: 80.80 (+0.42), FWP: 22.89 (-1.01), ALDW: 19.62 (+0.39), SUNE: 24.48 (+0.34), AIG: 55.94 (+0.29)

NOVAGOLD & Donlin Gold Collaborate to Feature a Way of Life in Alaska on Film
Marketwired - Wed Feb 11, 8:04AM CST
NOVAGOLD RESOURCES INC. (TSX: NG)(NYSE MKT: NG) is pleased to present the opening segment of a four-part video series on a way of life in Alaska - Yup'ik Language and Culture. The films tell a story about the people of the Yukon-Kuskokwim (Y-K) region, their heritage and subsistence way-of-life, as well as the challenges they face living in a remote community.
NG.TO: 4.03 (+0.17), NG: 3.05 (+0.03)

Why NovaGold Can Deliver More Upside Going Forward
Renu Singh - at Seeking Alpha - Tue Feb 10, 4:34PM CST

NG: 3.05 (+0.03)

The Companies Bob Moriarty Loves For The Long Term
The Gold Report - Seeking Alpha - Tue Feb 10, 10:20AM CST
The rapid and massive response when the Swiss unpegged the franc from the euro will ripple across the hedge fund, brokerage and financial systems. It also will infect other currencies, according to Bob Moriarty of 321gold.com. Gold, he believes,...
NG: 3.05 (+0.03), AAU: 0.93 (unch), NEM: 22.95 (+0.13), CDE: 5.34 (+0.35), GG: 19.17 (+0.56)

Increased Earnings Estimates Seen for NovaGold Resources (NG): Can It Move Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 05, 7:43AM CST
NovaGold Resources in the gold mining space is seeing solid activity on the earnings estimate revision front
NG: 3.05 (+0.03)

Update: NovaGold Reports Its 2014 Financials
Ben Kramer-Miller - at Seeking Alpha - Fri Jan 30, 10:38AM CST

NG: 3.05 (+0.03)

NovaGold's (NG) CEO Greg Lang on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Jan 29, 4:37PM CST

NG: 3.05 (+0.03)

NovaGold Resources EPS of -$0.13
Seeking Alpha - at Seeking Alpha - Thu Jan 29, 1:41AM CST

NG: 3.05 (+0.03)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading